What are the laboratory criteria for secondary prophylaxis of Spontaneous Bacterial Peritonitis (SBP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Secondary spontaneous bacterial peritonitis (SBP) prophylaxis should be initiated in cirrhotic patients who have had a previous episode of SBP, with the recommended regimen being norfloxacin 400 mg orally once daily or trimethoprim-sulfamethoxazole (TMP-SMX) double-strength tablet once daily as an alternative, as supported by the most recent and highest quality study 1. The rationale for secondary prophylaxis is that patients who have had one episode of SBP have a 70% chance of recurrence within one year without prophylaxis, as noted in 1.

Key Laboratory Criteria for Monitoring

Some key laboratory criteria that should be monitored during prophylaxis include:

  • Complete blood count to assess for neutropenia (a potential side effect of antibiotics)
  • Renal function tests (BUN, creatinine) to monitor kidney function
  • Liver function tests to track the progression of liver disease Additionally, ascitic fluid analysis should be performed if symptoms of SBP recur, looking for neutrophil count >250 cells/mm³, which indicates infection, as stated in 1.

Prophylaxis Duration and Rationale

Prophylaxis should be continued indefinitely or until liver transplantation or resolution of ascites, as the risk of recurrence remains high without prophylaxis, and antibiotic prophylaxis works by suppressing gut flora, particularly gram-negative bacteria, which are the most common causative organisms in SBP, as discussed in 1. Some alternative options, such as ciprofloxacin 500 mg orally once daily, can also be used if the other options are unavailable, but the effectiveness of quinolones in patients with MDRO or organisms other than gram-negatives is uncertain, as noted in 1.

From the Research

Secondary SBP Prophylaxis Labs Criteria

The following lab criteria are relevant for secondary SBP prophylaxis:

  • Ascitic fluid protein ≤1.5 g/dL 2, 3
  • Ascitic polymorphonucleated cell count <250/mm3 2
  • Presence of history of SBP 2, 4, 3, 5, 6
  • Child-Pugh score ≥9 points 3
  • Serum bilirubin ≥3 mg/dl 3
  • Impaired renal function 3

Antibiotic Prophylaxis

The use of antibiotic prophylaxis for secondary SBP prevention is supported by the following studies:

  • Norfloxacin 400 mg daily is effective for secondary prophylaxis 2, 4, 5, 6
  • Rifaximin 550 mg twice daily is more effective than norfloxacin for secondary prophylaxis 3
  • Trimethoprim-sulfamethoxazole has similar efficacy to norfloxacin for primary and secondary prophylaxis, but is associated with an increased risk of adverse events 4
  • Ciprofloxacin once weekly is not inferior to norfloxacin once daily for secondary prophylaxis 2, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.